208 related articles for article (PubMed ID: 33155291)
1. Proposal for modified inguinofemoral lymphadenectomy derived from investigation of anatomic distribution of sentinel and metastatic nodes in vulvar cancer.
Gu HF; Liu GC; Chen JP; Li JY; Zhang XK; Liu ZM; Tu H
J Surg Oncol; 2021 Feb; 123(2):660-666. PubMed ID: 33155291
[TBL] [Abstract][Full Text] [Related]
2. Lymph node count at inguinofemoral lymphadenectomy and groin recurrences in vulvar cancer.
van Beekhuizen HJ; Auzin M; van den Einden LC; de Hullu JA; van der Velden J; Wildhagen MF; van Doorn HC
Int J Gynecol Cancer; 2014 May; 24(4):773-8. PubMed ID: 24662136
[TBL] [Abstract][Full Text] [Related]
3. Groin surgery and risk of recurrence in lymph node positive patients with vulvar squamous cell carcinoma.
Nooij LS; Ongkiehong PJ; van Zwet EW; Bosse T; Creutzberg CL; Gaarenstroom KN; van Poelgeest MI
Gynecol Oncol; 2015 Dec; 139(3):458-64. PubMed ID: 26432039
[TBL] [Abstract][Full Text] [Related]
4. Reduced morbidity by using LigaSure compared to conventional inguinofemoral lymphadenectomy in vulvar cancer patients: A randomized controlled trial.
Pouwer AW; Arts HJ; Koopmans CM; IntHout J; Pijnenborg JMA; de Hullu JA
Surg Oncol; 2020 Dec; 35():149-155. PubMed ID: 32877884
[TBL] [Abstract][Full Text] [Related]
5. Long-term oncological outcomes of patients with negative sentinel lymph node in vulvar cancer. Comparative study with conventional lymphadenectomy.
Rodríguez-Trujillo A; Fusté P; Paredes P; Mensión E; Agustí N; Gil-Ibáñez B; Del Pino M; González-Bosquet E; Torné A
Acta Obstet Gynecol Scand; 2018 Dec; 97(12):1427-1437. PubMed ID: 30063814
[TBL] [Abstract][Full Text] [Related]
6. The number of removed lymph nodes by inguinofemoral lymphadenectomy: impact on recurrence rates in patients with vulva carcinoma.
Diehl A; Volland R; Kirn V; Thangarajah F; Eichler C; Einzmann T; Wirtz M; Ratiu D; Morgenstern B; Fridrich C; Mallmann P; Puppe J
Arch Gynecol Obstet; 2016 Jul; 294(1):131-6. PubMed ID: 26498758
[TBL] [Abstract][Full Text] [Related]
7. F-18 fluoro-D-glucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in planning of surgery and sentinel lymph node screening in vulvar cancers.
Dolanbay M; Ozcelik B; Abdulrezzak U; Serin IS; Kutuk MS; Uludag S
Arch Gynecol Obstet; 2016 Jun; 293(6):1319-24. PubMed ID: 26498604
[TBL] [Abstract][Full Text] [Related]
8. Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe.
Van der Kolk WL; Van der Zee AGJ; Slomovitz BM; Baldwin PJW; Van Doorn HC; De Hullu JA; Van der Velden J; Gaarenstroom KN; Slangen BFM; Kjolhede P; Brännström M; Vergote I; Holland CM; Coleman R; Van Dorst EBL; Van Driel WJ; Nunns D; Widschwendter M; Nugent D; DiSilvestro PA; Mannel RS; Tjiong MY; Boll D; Cibula D; Covens A; Provencher D; Runnebaum IB; Monk BJ; Zanagnolo V; Tamussino K; Oonk MHM;
Gynecol Oncol; 2022 Oct; 167(1):3-10. PubMed ID: 36085090
[TBL] [Abstract][Full Text] [Related]
9. Inguinal sentinel node dissection versus standard inguinal node dissection in patients with vulvar cancer: A comparison of the size of metastasis detected in inguinal lymph nodes.
Robison K; Steinhoff MM; Granai CO; Brard L; Gajewski W; Moore RG
Gynecol Oncol; 2006 Apr; 101(1):24-7. PubMed ID: 16246399
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II.
Oonk MHM; Slomovitz B; Baldwin PJW; van Doorn HC; van der Velden J; de Hullu JA; Gaarenstroom KN; Slangen BFM; Vergote I; Brännström M; van Dorst EBL; van Driel WJ; Hermans RH; Nunns D; Widschwendter M; Nugent D; Holland CM; Sharma A; DiSilvestro PA; Mannel R; Boll D; Cibula D; Covens A; Provencher D; Runnebaum IB; Luesley D; Ellis P; Duncan TJ; Tjiong MY; Cruickshank DJ; Kjølhede P; Levenback CF; Bouda J; Kieser KE; Palle C; Spirtos NM; O'Malley DM; Leitao MM; Geller MA; Dhar K; Asher V; Tamussino K; Tobias DH; Borgfeldt C; Lea JS; Bailey J; Lood M; Eyjolfsdottir B; Attard-Montalto S; Tewari KS; Manchanda R; Jensen PT; Persson P; Van Le L; Putter H; de Bock GH; Monk BJ; Creutzberg CL; van der Zee AGJ
J Clin Oncol; 2021 Nov; 39(32):3623-3632. PubMed ID: 34432481
[TBL] [Abstract][Full Text] [Related]
11. Evolution and outcomes of sentinel lymph node mapping in vulvar cancer.
Broach V; Abu-Rustum NR; Sonoda Y; Brown CL; Jewell E; Gardner G; Chi DS; Zivanovic O; Leitao MM
Int J Gynecol Cancer; 2020 Mar; 30(3):383-386. PubMed ID: 32075896
[TBL] [Abstract][Full Text] [Related]
12. Robot-assisted Sentinel Lymph Node Mapping and Inguinal Lymph Node Dissection Using Near-infrared Fluorescence in Vulvar Cancer.
Mohammad A; Hunter MI
J Minim Invasive Gynecol; 2019; 26(5):968-972. PubMed ID: 30959199
[TBL] [Abstract][Full Text] [Related]
13. Phase II activity trial of high-dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: GROningen INternational Study on Sentinel nodes in Vulvar cancer III (GROINSS-V III/NRG-GY024).
Gien LT; Slomovitz B; Van der Zee A; Oonk M
Int J Gynecol Cancer; 2023 Apr; 33(4):619-622. PubMed ID: 36653060
[TBL] [Abstract][Full Text] [Related]
14. [Feasibility and morbidity of sentinel lymph node detection in patients with vulvar carcinoma].
Carcopino X; Houvenaeghel G; Buttarelli M; Charaffe-Jauffret E; Gonzague L; Rossi I
Bull Cancer; 2005 May; 92(5):489-97. PubMed ID: 15932812
[TBL] [Abstract][Full Text] [Related]
15. Sentinel node assessment for diagnosis of groin lymph node involvement in vulval cancer.
Lawrie TA; Patel A; Martin-Hirsch PP; Bryant A; Ratnavelu ND; Naik R; Ralte A
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD010409. PubMed ID: 24970683
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node procedure in early-stage vulvar cancer: Correlation of lymphoscintigraphy with surgical outcome and groin recurrence.
Warmerdam DHM; van Geloven N; Beltman JJ; De Kroon CD; Rietbergen DDD; van Poelgeest MIE; Gaarenstroom KN
Eur J Surg Oncol; 2023 Oct; 49(10):107006. PubMed ID: 37572588
[TBL] [Abstract][Full Text] [Related]
17. Clinical Impact of Pelvic Sentinel Lymph Node Biopsy for Vulvar Squamous Cell Carcinoma.
Morgenstern B; Thangarajah F; Schmidt M; Lenz C
Anticancer Res; 2024 Jun; 44(6):2621-2626. PubMed ID: 38821614
[TBL] [Abstract][Full Text] [Related]
18. Correlation of Isotope Count With Sentinel Node Positivity in Vulvar Cancer.
Woelber L; Joosse SA; Grimm D; Mathey S; Mahner S; Burandt E; Klutmann S; Schmalfeldt B; Prieske K
Int J Gynecol Cancer; 2018 Sep; 28(7):1403-1409. PubMed ID: 29923853
[TBL] [Abstract][Full Text] [Related]
19. The potential risk of contralateral non-sentinel groin node metastasis in women with early primary vulvar cancer following unilateral sentinel node metastasis: a single center evaluation in University Hospital of Düsseldorf.
Winarno AS; Mondal A; Martignoni FC; Fehm TN; Hampl M
BMC Womens Health; 2021 Jan; 21(1):23. PubMed ID: 33435958
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma: a proposed protocol for a multicentre observational study.
van Doorn HC; Oonk MHM; Fons G; Gaarenstroom KN; de Hullu J; van Rosmalen J; van Beekhuizen HJ
BMC Cancer; 2022 Apr; 22(1):445. PubMed ID: 35461213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
